Zhao, Zhou, Chen, Xiufeng, Pang, Huayang, Shi, Yan, Sun, Hao (2025) Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis. PeerJ, 13. doi:10.7717/peerj.18871
| Reference Type | Journal (article/letter/editorial) | ||
|---|---|---|---|
| Title | Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis | ||
| Journal | PeerJ | ||
| Authors | Zhao, Zhou | Author | |
| Chen, Xiufeng | Author | ||
| Pang, Huayang | Author | ||
| Shi, Yan | Author | ||
| Sun, Hao | Author | ||
| Year | 2025 (January 27) | Volume | 13 |
| Publisher | PeerJ | ||
| DOI | doi:10.7717/peerj.18871Search in ResearchGate | ||
| Generate Citation Formats | |||
| Mindat Ref. ID | 17994616 | Long-form Identifier | mindat:1:5:17994616:5 |
| GUID | 0 | ||
| Full Reference | Zhao, Zhou, Chen, Xiufeng, Pang, Huayang, Shi, Yan, Sun, Hao (2025) Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis. PeerJ, 13. doi:10.7717/peerj.18871 | ||
| Plain Text | Zhao, Zhou, Chen, Xiufeng, Pang, Huayang, Shi, Yan, Sun, Hao (2025) Safety profile of EZH2 inhibitors for cancer: a systematic review and meta-analysis. PeerJ, 13. doi:10.7717/peerj.18871 | ||
| In | (2025) PeerJ Vol. 13. PeerJ | ||
References Listed
These are the references the publisher has listed as being connected to the article. Please check the article itself for the full list of references which may differ. Not all references are currently linkable within the Digital Library.
| Not Yet Imported: - journal-article : 10.1016/j.annonc.2021.08.1099 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1038/s41417-022-00555-1 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1200/JCO.2021.39.15_suppl.11563 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1200/JCO.2022.40.16_suppl.10040 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: JNCI: Journal of the National Cancer Institute - journal-article : 10.1093/jnci/djad085 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Choudhury (2024) Clinical Cancer Research A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer 30, 3697 | |
| Not Yet Imported: - journal-article : 10.5582/ddt.2022.01085 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Eisai (2022) Study of tazemetostat in participants with relapsed or refractory B-cell non-hodgkin’s lymphoma With EZH2 gene mutation | |
| Not Yet Imported: - journal-article : 10.1200/JCO.2023.41.16_suppl.2507 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Gold (2024) Journal of Clinical Investigation Epigenetic therapies targeting histone lysine methylation: complex mechanisms and clinical challenges 134, e183391 | |
| Not Yet Imported: - journal-article : 10.1016/S1470-2045(20)30451-4 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: Clinical Cancer Research - journal-article : 10.1158/1078-0432.CCR-23-2174 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1093/annonc/mdy048.001 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: Drugs - journal-article : 10.1007/s40265-020-01288-x If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1021/acs.jmedchem.2c01607 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Hussain (2024) A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183) | |
| Not Yet Imported: - journal-article : 10.1016/S1470-2045(18)30145-1 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1182/blood.2022016862 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1016/j.canlet.2024.216706 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1007/s40265-022-01800-5 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.7150/thno.83353 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
 | Liu, Linshan, Xiao, Bin, Hirukawa, Alison, Smith, Harvey W., Zuo, Dongmei, Sanguin-Gendreau, Virginie, McCaffrey, Luke, Nam, Alice Jisoo, Muller, William J. (2023) Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways. Proceedings of the National Academy of Sciences, 120 (33) doi:10.1073/pnas.2303010120 |
| Not Yet Imported: - journal-article : 10.1007/s12032-023-02025-6 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1016/j.ejphar.2023.175590 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| MedDRA (2018) Introductory guide for standardised MeDRa queries (SMQs) Version 21.0 | |
| Not Yet Imported: - journal-article : 10.1016/S1470-2045(20)30441-1 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1007/s00280-024-04658-4 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1186/s13643-021-01626-4 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Palmieri (2023) Targeting EZH2 to overcome the resistance to immunotherapy in microsatellite stable colorectal cancer: results from the CAIRE study | |
| Not Yet Imported: - journal-article : 10.1016/j.clml.2021.12.014 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: Journal of Clinical Oncology - journal-article : 10.1200/JCO.2023.41.16_suppl.6022 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Romero, Pierre, Richart, Laia, Aflaki, Setareh, Petitalot, Ambre, Burton, Megan, Michaud, Audrey, Masliah-Planchon, Julien, Kuhnowski, Frédérique, Le Cam, Samuel, Baliñas-Gavira, Carlos, Méaudre, Céline, Luscan, Armelle, Hamza, Abderaouf, Legoix, Patricia, Vincent-Salomon, Anne, Wassef, Michel, Holoch, Daniel, Margueron, Raphaël (2024) EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition. Nature Communications, 15 (1) doi:10.1038/s41467-024-47701-x |
| Not Yet Imported: Clinical Epigenetics - journal-article : 10.1186/s13148-023-01452-6 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Sabour-Takanlou (2024) Clinical Genetics EZH2-associated tumor malignancy: a prominent target for cancer treatment 106, 377 | |
| Not Yet Imported: - journal-article : 10.1182/blood-2023-179910 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1158/1078-0432.CCR-19-3741 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1016/j.annonc.2022.07.616 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Shah (2022) Common terminology criteria for adverse events | |
| Not Yet Imported: - journal-article : 10.1046/j.1445-2197.2003.02748.x If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1158/1078-0432.CCR-23-2582 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1016/S2352-3026(22)00134-X If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.6004/jadpro.2022.13.2.7 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1002/cpdd.1315 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1080/13543776.2023.2206018 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1158/1078-0432.CCR-18-4121 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Not Yet Imported: - journal-article : 10.1016/S1470-2045(22)00277-7 If you would like this item imported into the Digital Library, please contact us quoting Journal ID | |
| Zinzani (2024) The Lancet Oncology Valemetostat for patients with relapsed or refractory peripheral T-cell lymphoma (VALENTINE-PTCL01): a multicentre, open-label, single-arm, phase 2 study 25, 1602 |
See Also
These are possibly similar items as determined by title/reference text matching only.
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|